Correction: Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction - Summary - MDSpire
Advertisement
Correction: Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction
To assess the role of serum levels of APRIL, BAFF, and IL-10 as potential biomarkers for disease activity and flare prediction in systemic lupus erythematosus (SLE).
Key Findings:
No significant differences in serum levels of APRIL, BAFF, and IL-10 were found between SLE patients and healthy controls.
Cytokine levels did not vary significantly between SLE patients with and without prior cyclophosphamide treatment.
The study suggests limited utility of these cytokines as biomarkers for disease activity and flare prediction in SLE.
Interpretation:
The findings indicate that APRIL, BAFF, and IL-10 may not serve as reliable biomarkers for monitoring disease activity or predicting flares in systemic lupus erythematosus.
Limitations:
Potential selection bias in the enrolled patient population.
Limited sample size may affect the generalizability of the results.
The study did not explore other potential biomarkers that could be relevant.
Conclusion:
The study concludes that serum levels of APRIL, BAFF, and IL-10 have a limited role in predicting disease activity and flares in SLE, warranting further research into alternative biomarkers.
by Gabriela Rybka, Radosław Dziedzic, Kazimierz Węglarczyk, Mamert Milewski, Andżelika Siwiec-Koźlik, Sylwia Dziedzina, Marek Sanak, Jacek Musiał, Maciej Siedlar, Mariusz Korkosz, Joanna Kosałka-Węgiel
